Clinical trial
A Phase II Trial of Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.
NCT04749602 is registered in ClinicalTrials.gov with Kidney Cancer Research Bureau as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.
- Lead sponsor
- Kidney Cancer Research Bureau
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 10, 2020
- Completion date
- March 1, 2023
- Enrollment
- 26 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer metastatic, pleural effusion, malignant, renal cell cancer metastatic